Maroteaux-Lamy syndrome is a very rare multisystem disorder. Cardiac valve surgery is common in these patients who present a unique set of perioperative and intraoperative challenges to the surgeon and treating team. We describe successful mitral valve replacement using an inverted aortic prosthesis in a 29-year-old lady with Maroteaux-Lamy syndrome, with a good result at 10 months.
ValayannopoulosVNicelyHHarmatzPTurbevilleS. Mucopolysaccharidosis VI. Orphanet J Rare Dis2010; 5: 5–5.
2.
RiganteDSegniG. Cardiac structural involvement in mucopolysaccharidosis. Cardiology2002; 98: 18–20.
3.
BhattacharyaKGibsonSCPathiVL. Mitral valve replacement for mitral stenosis secondary to Hunter’s syndrome. Ann Thorac Surg2005; 80: 1911–1912.
4.
BraunlinERosenfeldHKampmannCet al.Enzyme replacement therapy for mucopolysaccharide VI: long-term cardiac effects of galsulfase (Naglazyme®) therapy. J Inherit Metab Dis2013; 36: 385–394.
5.
BrandsMMHoogeveen-WesterveldMKroosMAet al.Mucopolysaccharidosis type VI phenotypes-genotypes and antibody response to galsulfase. Orphanet J Rare Dis2013; 8: 51–51.
6.
SayilganCYuceyarLAkbasSErolcayH. Anesthesia in a child with Maroteaux-Lamy syndrome undergoing mitral valve replacement. Clinics (Sao Paulo)2012; 67: 693–696.
7.
KitabayashiKMatsumiyaGIchikawaHMatsueHShimamuraKSawaY. Surgical treatment for mitral stenosis in Scheie’s syndrome: mucopolysaccharidosis type I-S. Ann Thorac Surg2007; 84: 654–655.
8.
AttisaniMPellegriniASorrentinoPRinaldiM. Enlargement of mitral valve ring in a young woman with severe prosthesis-patient mismatch. Heart Surg Forum2014; 17: E61–E63.
9.
MarwickTHBastianBHughesCFBaileyBP. Mitral stenosis in the Maroteaux Lamy syndrome: a treatable cause of dyspnea. Portgrad Med J1992; 68: 287–288.
